Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Matthew Hassink
Introduction
Matthew Hassink is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of science and technology, particularly in the area of radionuclide labeled probes. His work has implications for medical imaging and diagnostics.
Latest Patents
Hassink holds a patent titled "Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes." This patent describes a Diels-Alder adduct of a trans-cyclooctene with a tetrazine, which includes a substituent labeled with a radionuclide. The method outlined in the patent allows for the production of PET or other images of organs in animals or humans by forming the Diels-Alder adduct within the subject.
Career Highlights
Throughout his career, Matthew Hassink has worked at prestigious institutions such as the University of Delaware and the University of Southern California. His experience in these academic environments has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hassink has collaborated with notable colleagues, including Joseph M. Fox and Melissa Blackman. These partnerships have likely enriched his research and led to innovative developments in his field.
Conclusion
Matthew Hassink's work exemplifies the intersection of innovation and practical application in medical imaging. His contributions continue to influence advancements in the field, showcasing the importance of research and collaboration in driving scientific progress.